What we do Evoq Remedies Ltd markets, trades, and distributes pharmaceutical formulations and raw materials, focusing on affordable healthcare products across Gujarat. |
Founded in 2,010 |
Market share Recognized trading house for pharmaceuticals raw materials and formulations in Gujarat. |
Problem solved Provides affordable access to pharmaceutical raw materials and finished formulations, facilitating healthcare availability. |
Top clients or who we serve Serves pharmaceutical companies and healthcare providers primarily in Gujarat; B2B focus. |
Key management Bhumishth Patel (Managing Director), Payal Patel (Former Managing Director), Harsh Kothari (Chairperson of Audit Committee). |
Our journey and innovations Started operations in 2018; converted to a public company in 2021; raised Rs. 9.72 crore via IPO in 2022. |
Where we operate Primarily operating in Ahmedabad, Gujarat, India. |
Top products or what we offer Markets 120+ pharmaceutical formulations under own brand; trades APIs, excipients, bulk drugs. |
Top brands - |
Raw materials needed APIs, excipients, bulk drugs sourced for pharmaceutical formulations. |
Raw materials supplier Third-party manufacturers. |
Recurring vs cyclical contribution Revenue mainly from trading and marketing; recurring through ongoing pharmaceutical supply contracts. |
Our industry position Established pharmaceutical raw materials trader with growing presence in regional pharmaceutical markets. |
Financial highlights FY 2024-25 revenue Rs. 11.76 crore, net profit Rs. 0.09 crore, showing growth over previous year. |
Geographical revenue split - |
Order book - |
Whats driving growth Increasing healthcare demand in Gujarat and expanding pharmaceutical marketing and trading operations. |
Our future plans Seeking new growth avenues with expanded operations and increased capital base after IPO. |
Our green promise - |
Our people and values Focus on compliance, ethics, and board evaluation to enhance governance and corporate responsibility. |
Key challenges ahead Tax litigations, SEBI investigations, and regulatory compliance risks impact financial stability. |
Interesting facts Converted from private to public company within 11 years; raised significant funds via IPO in 2022. |
Risks and strategy Contesting regulatory and tax challenges; improving internal controls and compliance to mitigate risks. |
